The purpose of this study is to compare the sustained virological response rate at 24 weeks
after the end of experimental treatment (induction and 72 weeks) to that of standard 48 weeks
treatment with PEG-inteferon alfa-2b and ribavirin in patients with chronic hepatitis C
previous unresponsive to interferon alfa monotherapy or interferon alfa/ribavirin combination
therapy.